content: <HTML>
  <HEAD>
  <TITLE></TITLE>
  </HEAD>
  <BODY>
  
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pursuant to Section 13 OR 15(d) of The Securities
  Exchange Act of 1934</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of earliest event reported):
  <B>July 25, 2013</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>GREENESTONE HEALTHCARE CORPORATION</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its
  charter)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><B>Colorado</B></FONT></TD>
      <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><B>000-15078</B></FONT></TD>
      <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><B>84-1227328</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(State or other jurisdiction of</P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">incorporation or organization)</P></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(IRS Employer</P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Identification No.)</P></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>5734 Yonge Street, Suite 300</B>,
  <B>North York, Ontario, Canada M2M 4E7</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">(Address of principal executive offices)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><B>(416) 222-5501</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">(Registrant&rsquo;s telephone number, including area code)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Written communications pursuant to Rule
  425 under the Securities Act</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Soliciting material pursuant to Rule 14a-12
  under the Exchange Act</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Pre-commencement communications pursuant
  to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Pre-commencement communications pursuant
  to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;&nbsp;</P>
  
  <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Prepared By:</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="http:||www.sec.gov|Archives|edgar|data|792935|000139160913000227|image_001.jpg" STYLE="height: 49; width: 105"></P>
  
  <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Sunny J. Barkats, Esq.</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 11pt"><B><I>JSBarkats,</I></B></FONT><B><FONT STYLE="font-size: 8pt">
  </FONT><FONT STYLE="font-size: 5pt">PLLC</FONT></B></P>
  
  <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">18 East 41<SUP>st</SUP> Street, 19<SUP>th</SUP>
  Floor</P>
  
  <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">New York, NY 10017</P>
  
  <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">P: (646) 502-7001</P>
  
  <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">F: (646) 607-5544</P>
  
  <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>www.JSBarkats.com</B></P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 1.01&#9;Entry into a Material Definitive Agreement.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 25, 2013, Greenestone Healthcare Corporation,
  a Colorado corporation, closed a Securities Purchase Agreement (the &ldquo;Agreement&rdquo;) with Asher Enterprises, Inc., a Delaware
  corporation (the &ldquo;Investor&rdquo;), pursuant to which the Company sold to the Investor a convertible note in the amount of
  $63,000, bearing interest at the rate of 8% per annum (the &ldquo;Convertible Note&rdquo;). The Convertible Note contains customary
  default provisions, including provisions for potential acceleration of the Convertible Note, a default premium and a default interest
  rate. The Convertible Note is payable, along with interest thereon, on April 15, 2014.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has the option to prepay the Note,
  along with an interest premium, at any time during the first 180 days after issuance, such issuance premium dependent on the date
  of prepayment. Upon the occurrence of an event of default, as described in the Convertible Note, the Investor can declare the entire
  amount of principal and interest then due on the Convertible Note immediately due and payable and require the Company to pay a
  premium default payment.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The principal balance of the Convertible Note
  is convertible into shares of the Company&rsquo;s common stock, par value $0.01 per share, at the election of the Holder, beginning
  180 days after the issuance of the Convertible Note. The conversion price is equal to the Market Price (as such term is defined
  in the Convertible Note) multiplied by 61%. The Investor is prohibited from converting the Convertible Note into shares of the
  Company&rsquo;s common stock to the extent that such conversion would result in the Investor beneficially owning more than 4.99%
  of the Company&rsquo;s common stock, subject to 61 days prior written notice to the Company from the Investor of the Investor&rsquo;s
  intention to waive or modify such provision.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The foregoing description of the Convertible
  Note and the Securities Purchase Agreement do not purport to be complete and are qualified in their entirety by reference to the
  Convertible Note and the Securities Purchase Agreement, which are filed as Exhibits 4.1 and 10.1, respectively, to this Current
  Report on Form 8-K and are incorporated herein by reference.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Item 2.03&#9;Creation of a Direct Financial
  Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The information required to be disclosed in
  this Item 2.03 is incorporated herein by reference from Item 1.01.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Item 3.02&#9;Unregistered Sales of Equity
  Securities.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The securities described in Item 1.01 above
  and 8.01 below were offered and sold in reliance upon exemptions from registration pursuant to Section 4(2) under the Securities
  Act of 1933, as amended (&ldquo;Securities Act&rdquo;), and Rule 506 of Regulation D promulgated thereunder. The offerings were
  made to &ldquo;accredited investors&rdquo; (as defined by Rule 501 under the Securities Act). In addition, the issuances did not
  involve a public offering; the Company made no solicitation in connection with the sale other than communications with the investors;
  the Company obtained representations from the investors regarding its investment intent, experience and sophistication; and the
  investors either received or had access to adequate information about the Company in order to make an informed investment decision.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Item 8.01&#9;Other Events.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 26, 2013, the Company entered into
  a letter agreement with Colebrooke Capital, Inc. (&ldquo;Colebrooke&rdquo;), pursuant to which, for a period of four (4) months,
  Colebrooke will serve as the Company&rsquo;s non-exclusive strategic advisor for financing and strategic opportunities.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Item 9.01 Financial Statements and Exhibits.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>(d) Exhibits</I></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 12%; border-bottom: windowtext 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Exhibit No.</FONT></TD>
      <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="width: 86%; border-bottom: windowtext 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Description</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt">$63,000 Convertible Promissory Note, dated July 25, 2013, issued in favor of Asher Enterprises, Inc. *</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">10.1</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt">Securities Purchase Agreement, dated July 25, 2013, by and between Greenestone Healthcare Corporation and Asher Enterprises, Inc. *</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>
  
  
  <!-- Field: Page; Sequence: 3 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities
  Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD COLSPAN="3" STYLE="padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>GREENESTONE HEALTHCARE CORPORATION</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="width: 2%; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="width: 46%; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt">Date: July 31, 2013</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
      <TD STYLE="border-bottom: windowtext 1pt solid; padding-left: 5.4pt; font-style: italic">/s/ Shawn E. Leon</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt">Name: Shawn E. Leon</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <!-- Field: Page; Sequence: 4; Options: Last -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>
  
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "grst8k073013main.htm", "secsgml_size_bytes": 22673}]
metadata_filer: {"company-data": {"conformed-name": "GREENESTONE HEALTHCARE CORP", "cik": "0000792935", "assigned-sic": "8062", "irs-number": "841227328", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-15078", "film-number": "13997703"}, "business-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7", "phone": "416-222-5501"}, "mail-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7"}, "former-company": {"former-conformed-name": "NOVA NATURAL RESOURCES CORP", "date-changed": "19920703"}}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 OR 15(d) of The Securities
  Exchange Act of 1934
  Date of Report (Date of earliest event reported):
  July 25, 2013
  GREENESTONE HEALTHCARE CORPORATION
  (Exact name of registrant as specified in its
  charter)
  Colorado
  000-15078
  84-1227328
  (State or other jurisdiction of
  incorporation or organization)
  (Commission File Number)
  (IRS Employer
  Identification No.)
  5734 Yonge Street, Suite 300
  ,
  North York, Ontario, Canada M2M 4E7
  (Address of principal executive offices)
  (416) 222-5501
  (Registrant's telephone number, including area code)
  Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  [ ] Written communications pursuant to Rule
  425 under the Securities Act
  [ ] Soliciting material pursuant to Rule 14a-12
  under the Exchange Act
  [ ] Pre-commencement communications pursuant
  to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [ ] Pre-commencement communications pursuant
  to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  Prepared By:
  Sunny J. Barkats, Esq.
  JSBarkats,
  PLLC
  18 East 41
  st
  Street, 19
  th
  Floor
  New York, NY 10017
  P: (646) 502-7001
  F: (646) 607-5544
  www.JSBarkats.com
  Item 1.01	Entry into a Material Definitive Agreement.
  On July 25, 2013, Greenestone Healthcare Corporation,
  a Colorado corporation, closed a Securities Purchase Agreement (the "Agreement") with Asher Enterprises, Inc., a Delaware
  corporation (the "Investor"), pursuant to which the Company sold to the Investor a convertible note in the amount of
  $63,000, bearing interest at the rate of 8% per annum (the "Convertible Note"). The Convertible Note contains customary
  default provisions, including provisions for potential acceleration of the Convertible Note, a default premium and a default interest
  rate. The Convertible Note is payable, along with interest thereon, on April 15, 2014.
  The Company has the option to prepay the Note,
  along with an interest premium, at any time during the first 180 days after issuance, such issuance premium dependent on the date
  of prepayment. Upon the occurrence of an event of default, as described in the Convertible Note, the Investor can declare the entire
  amount of principal and interest then due on the Convertible Note immediately due and payable and require the Company to pay a
  premium default payment.
  The principal balance of the Convertible Note
  is convertible into shares of the Company's common stock, par value $0.01 per share, at the election of the Holder, beginning
  180 days after the issuance of the Convertible Note. The conversion price is equal to the Market Price (as such term is defined
  in the Convertible Note) multiplied by 61%. The Investor is prohibited from converting the Convertible Note into shares of the
  Company's common stock to the extent that such conversion would result in the Investor beneficially owning more than 4.99%
  of the Company's common stock, subject to 61 days prior written notice to the Company from the Investor of the Investor's
  intention to waive or modify such provision.
  The foregoing description of the Convertible
  Note and the Securities Purchase Agreement do not purport to be complete and are qualified in their entirety by reference to the
  Convertible Note and the Securities Purchase Agreement, which are filed as Exhibits 4.1 and 10.1, respectively, to this Current
  Report on Form 8-K and are incorporated herein by reference.
  Item 2.03	Creation of a Direct Financial
  Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
  The information required to be disclosed in
  this Item 2.03 is incorporated herein by reference from Item 1.01.
  Item 3.02	Unregistered Sales of Equity
  Securities.
  The securities described in Item 1.01 above
  and 8.01 below were offered and sold in reliance upon exemptions from registration pursuant to Section 4(2) under the Securities
  Act of 1933, as amended ("Securities Act"), and Rule 506 of Regulation D promulgated thereunder. The offerings were
  made to "accredited investors" (as defined by Rule 501 under the Securities Act). In addition, the issuances did not
  involve a public offering; the Company made no solicitation in connection with the sale other than communications with the investors;
  the Company obtained representations from the investors regarding its investment intent, experience and sophistication; and the
  investors either received or had access to adequate information about the Company in order to make an informed investment decision.
  Item 8.01	Other Events.
  On July 26, 2013, the Company entered into
  a letter agreement with Colebrooke Capital, Inc. ("Colebrooke"), pursuant to which, for a period of four (4) months,
  Colebrooke will serve as the Company's non-exclusive strategic advisor for financing and strategic opportunities.
  Item 9.01 Financial Statements and Exhibits.
  (d) Exhibits
  Exhibit No.
  Description
  4.1
  $63,000 Convertible Promissory Note, dated July 25, 2013, issued in favor of Asher Enterprises, Inc. *
  10.1
  Securities Purchase Agreement, dated July 25, 2013, by and between Greenestone Healthcare Corporation and Asher Enterprises, Inc. *
  SIGNATURES
  Pursuant to the requirements of the Securities
  Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
  GREENESTONE HEALTHCARE CORPORATION
  Date: July 31, 2013
  By:
  /s/ Shawn E. Leon
  Name: Shawn E. Leon
  Title: Chief Executive Officer